
The scope of the paper is to zzso key issues in methodology used in clinical trials on multiple sclerosis zzso treatment and help clinicians to better understand articles reporting the results of these zzso zzso ratio and disability progression based on the Expanded zzso zzso zzso are currently used as clinical efficacy primary zzso but more global zzso should be used in future such as the zzso zzso zzso For magnetic resonance imaging zzso zzso new zzso zzso and indexes are already available zzso score, conventional zzso zzso that, together with new zzso techniques zzso transfer zzso and zzso resonance zzso offer more precise zzso assessments of the zzso These efficacy zzso should be presented in articles as number needed to treat, which assists the reader to calculate and compare the zzso power and zzso 

